IRONWOOD PHARMACEUTICALS INC (IRWD): debt financing — Ironwood to acquire VectivBio for $17.00/share; secures $500M credit facility

IRONWOOD PHARMACEUTICALS INC

Cash tender offer at $17.00/share for all VectivBio shares; minimum tender condition >80%.
Termination fees: VectivBio pays $23.68M if superior proposal; Ironwood pays $59.2M reverse fee.
$500M revolving credit facility from Wells Fargo; matures 2027; secured by substantially all assets.
Support agreement with shareholders owning ~28.6% of VectivBio shares agreeing to tender and vote.
VectivBio shareholders must remove voting cap and elect Ironwood designees to board.

item 1.01 item 2.03 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.7

IRONWOOD PHARMACEUTICALS INC incurred revolving credit.

Instrument: revolving credit
Event: incurrence

Exact text from the filing

The information included under Item 1.01 above under the heading "Revolving Credit Agreement" is incorporated herein by reference.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

IRONWOOD PHARMACEUTICALS INC entered into Transaction Agreement with VectivBio Holding AG (effective 2023-05-21).

Action: entry
Agreement: merger
Counterparty: VectivBio Holding AG
Effective: 2023-05-21

Exact text from the filing

On May 21, 2023, Ironwood Pharmaceuticals, Inc., a Delaware corporation (“Ironwood”), entered into a Transaction Agreement (the “Transaction Agreement”) with VectivBio Holding AG

View on SEC.gov

222 debt financings filed in the last 30 days. Browse all debt financings →

IRONWOOD PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001104659-23-063162

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.